RA PHARMACEUTICALS INC's ticker is RARX and the CUSIP is 74933V108. A total of 1 filers reported holding RA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $36,243,000 | -55.8% | 754,909 | -56.8% | 0.03% | -44.1% |
| Q4 2019 | $81,963,000 | +6569.1% | 1,746,496 | +3260.5% | 0.06% | +5800.0% |
| Q3 2019 | $1,229,000 | -25.7% | 51,972 | -5.5% | 0.00% | 0.0% |
| Q2 2019 | $1,653,000 | +1867.9% | 54,969 | +1382.0% | 0.00% | – |
| Q1 2019 | $84,000 | +47.4% | 3,709 | +18.6% | 0.00% | – |
| Q4 2018 | $57,000 | +1.8% | 3,127 | +1.5% | 0.00% | – |
| Q3 2018 | $56,000 | +409.1% | 3,082 | +38.5% | 0.00% | – |
| Q1 2018 | $11,000 | +450.0% | 2,225 | +1083.5% | 0.00% | – |
| Q4 2017 | $2,000 | – | 188 | +9300.0% | 0.00% | – |
| Q3 2017 | $0 | -100.0% | 2 | -98.4% | 0.00% | – |
| Q2 2017 | $2,000 | 0.0% | 126 | +20.0% | 0.00% | – |
| Q1 2017 | $2,000 | -98.4% | 105 | -98.7% | 0.00% | – |
| Q4 2016 | $125,000 | – | 8,263 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 6,138,797 | $294,724,000 | 15.40% |
| RA Capital Management | 4,858,260 | $233,245,000 | 7.37% |
| HAVENS ADVISORS LLC | 143,266 | $6,878,000 | 6.70% |
| BARDIN HILL MANAGEMENT PARTNERS LP | 609,614 | $29,267,000 | 6.40% |
| OMNI PARTNERS LLP | 1,052,744 | $50,542,000 | 4.45% |
| HBK INVESTMENTS L P | 2,004,042 | $96,214,000 | 4.03% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 2,005,600 | $96,289,000 | 3.83% |
| Versor Investments LP | 1,108,845 | $53,236,000 | 3.53% |
| OXFORD ASSET MANAGEMENT LLP | 461,016 | $22,133,000 | 3.12% |
| HighVista Strategies LLC | 63,222 | $3,035,000 | 2.81% |